Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Knome's KnomeClinic

Premium

Knome has begun an early-access program for knomeClinic, a software suite designed to help medical researchers and clinicians interpret human genomes.

The company said that clinics accepted into the program will be given "installation priority, access to pilot programs and pre-release prototypes, and the ability to influence knomeClinic's feature set upon general release."

The knomeClinc suite is built upon the company's kGAP informatics and annotation platform, which accepts raw sequence data from major sequencing platforms and generates standardized, annotated data sets.

Knome has not provided a timeline for the commercial release of knomeClinic, but said that when it is available it will include desktop interpretation-support applications; a database of curated reference data containing more than 100,000 genotype-phenotype associations; and software that will allow researchers, physicians, and medical institutions to "curate and prioritize genotype-phenotype associations, whether publically available or self-generated."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more